Revance Therapeutics | 应收帐款人



应收帐款人 更改 日
AbbVie USD 12.77B 132M 2025-09
ALKERMES USD 355.11M 1.22M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Coherus Biosciences USD 62.44M 59.9M 2025-03
Eli Lilly USD 19.46B 2.25B 2025-09
J&J USD 17.61B 235M 2025-09
Merck USD 12.12B 596M 2025-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
P&G USD 6.28B 208M 2025-12
Pacira USD 115.27M 901K 2025-09
Supernus Pharmaceuticals USD 171.25M 30.42M 2025-09


Revance Therapeutics 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.